Europe Fluoroscopy Market

Europe Fluoroscopy Market Size (2024 to 2029)

The European market for Fluoroscopy was worth USD 532.91 million in 2024 and is estimated to be growing at a CAGR of 3.0% to reach USD 617.79 million by 2029. Fluoroscopy is the imaging innovation that utilizes an x-ray to acquire ongoing moving pictures of the inside of the body.

As per the 2017 European cardiovascular disease statistics, over the past two decades, the absolute number of CVD cases were increased in Europe, with the number of new CVD cases rising in most countries. In 2010, the incidence of cardiovascular disease was approximately 6.8 million. However, that number has grown to over 8.7 million by 2020. As cardiovascular disease increases in Europe, the demand for early diagnostic techniques such as fluoroscopy is expected to increase. It should help the market in the future. The European market is competitive because of the presence of almost all the global fluoroscopy market players. Many of these international players are based in European countries, increasing fluoroscopy devices' accessibility across Europe.

The European fluoroscopy market is anticipated to experience significant growth, with an elevating figure of high-precision minimally invasive surgeries, including the devices in utilization, emerging in better support for patients and surgeons. Rising prevalence for minimally invasive procedures is due to benefits, such as the lower risk of complications, lower cost and shorter recovery period, less pain, smaller incisions, and less scarring, contributing to market growth. The use of fluoroscopy in pain management is expected to complement the market growth.

However, the radiation risk from exposure to x-ray images is one of the significant factors limiting the growth of the Europe fluoroscopy equipment market. High exposure to ionizing radiation can increase the risk of cancer and radiation-induced burns. Besides, a shortage of medical professionals and a lack of awareness of innovative applications are other factors that are expected to hamper the Europe fluoroscopy equipment market's growth during the forecast period.

This research report on the Europe Fluoroscopy Market has been segmented and sub-segmented into the following categories.

• By Surgery Type: Cardiovascular interventions, Biopsy, Orthopedic surgeries, and Others
• By End User: Hospitals, Diagnostic Centers, and Clinics
• By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, and Rest of Europe

Regional Analysis

In Western Europe, in countries like the UK, Belgium, France, and Ireland, a significant amount of fluoroscopy equipment needs to be replaced. Simultaneously, the technology and digitization of fluoroscopy equipment will have a strong influence on purchasing mechanisms. Due to stricter radiation dose regulations, providers are adapting equipment to meet new standards, while at the same time building hybrid fluoroscopy and radiography to attract healthcare facilities. Due to changes in radiation dose regulations, fluoroscopy procedures are expected to receive established reimbursements. Therefore, more market participants are expected to launch products in this segment and exhibit various clinical applications, and hence the competitive scene in Western Europe is expected to increase.

Key market participants dominating the European Fluoroscopy market profiled in this report are Philips Healthcare, GE Healthcare, Siemens Medical Solutions, Shimadzu Medical Systems, Shanghai Bojin Medical Instrument Co., Ltd, and Toshiba Medical Systems Corp.